Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks
Clinical trial NCT02232061 · COMPLETED
Trial details
- NCT number
- NCT02232061
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-29
- Primary completion
- 2020-01-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.